CATALENT, INC.

(A112H2)
  Bericht
Verzögert Nyse  -  22:04 24.06.2022
109.61 USD    0.00%
13.06.INSIDER-VERKAUF : Catalent
MT
04.05.CATALENT, INC. : Morgan Stanley behält seine Kaufempfehlung bei
MM
04.05.CATALENT, INC. : erhält Kaufen-Rating von UBS
MM
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über CATALENT, INC.
13.06.INSIDER SELL : Catalent
10.06.Catalent Supports U.S. Launch of Phathom Pharmaceuticals' New Products Following Regula..
08.06.TRANSCRIPT : Catalent, Inc. Presents at 2022 Jefferies Global Healthcare Conference, Jun-0..
07.06.TRANSCRIPT : Catalent, Inc. Presents at William Blair’s 42nd Annual Growth Stock Conf..
07.06.CATALENT : and MigVax Sign Agreement to Develop an Orally Disintegrating Freeze-Dried Tabl..
27.05.Catalent, Inc. to Present at June Investor Conferences
20.05.Catalent Invests $175 Million to Expand Manufacturing Capabilities and Capacity at Winc..
17.05.Catalent Launches UpTempo Virtuoso AAV Platform to Reduce Gene Therapy Development Time..
11.05.TRANSCRIPT : Catalent, Inc. Presents at Bank of America 2022 Healthcare Conference, May-11..
03.05.SECTOR UPDATE : Health Care Advance Led Higher by Biotechs
03.05.SECTOR UPDATE : Health Care
03.05.Catalent Reports Increase in Fiscal Q3 Adjusted Net Income, Revenue; Raises FY2022 Targ..
03.05.CATALENT, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
03.05.TRANSCRIPT : Catalent, Inc., Q3 2022 Earnings Call, May 03, 2022
03.05.CATALENT : Fiscal Q3 Earnings Snapshot
03.05.Catalent, Inc. Reports Third Quarter Fiscal 2022 Results
03.05.Earnings Flash (CTLT) CATALENT Posts Q3 Revenue $1.27B, vs. Street Est of $1.22B
03.05.Catalent, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Mar..
03.05.Catalent, Inc. Raises Revenue Guidance for the Full Year of 2022
03.05.CATALENT : CTLT FY22 Q3 Earnings Call Presentation
28.04.CATALENT : Expands Nasal Drug Development and Manufacturing Capabilities at Morrisville, N..
25.04.CATALENT : Acquires Commercial-Scale Cell Therapy Development and Manufacturing Facility i..
25.04.Catalent, Inc. acquired Commercial-Scale Cell Therapy Development and Manufacturing Fac..
25.04.Catalent, Inc. acquired Cell therapy manufacturing facility in Princeton, New Jersey of..
21.04.CATALENT : to Invest $350 Million in Integrated Biologics Drug Substance and Drug Product ..
20.04.Expanding Operations In Biologics
18.04.Catalent Adds 4 New Encapsulation Manufacturing Suites at Kansas City Facility
15.04.WEEKLY MARKET UPDATE : The market stopped its rise
15.04.Catalent, Inc. Announces Third Quarter Fiscal Year 2022 Earnings Conference Webcast
14.04.CATALENT : Adds New High-Throughput Encapsulation Manufacturing Suites at Kansas City, Mis..
07.04.Marvel biosciences initiates formulation development with catalent
06.04.Marvel Biosciences Corp. Initiates Its Pre-Clinical Oral Formulation Studies for Its Le..
06.04.CATALENT : Acquires Facility in Oxfordshire to Expand Biologics Capabilities in the UK and..
06.04.Catalent, Inc. acquired Biologics development and manufacturing facility of VMIC Ltd.
23.03.Catalent, Inc. Provides Earning Guidance for 2022
23.03.TRANSCRIPT : Catalent, Inc. Presents at 2022 KeyBanc Capital Markets Life Sciences and Med..
18.03.Catalent, Inc. to Present at the KeyBanc Life Sciences & MedTech Investor Forum
17.03.CATALENT : Appoints Frederic Cedrone as Vice President, Corporate Innovation
16.03.CATALENT : Biologics Completes $30 Million Project for Biopharmaceutical Development and D..
10.03.Catalent Publishes Third Annual Corporate Responsibility Report
03.03.CATALENT : Expands Temperature-Controlled Clinical Supply Capabilities in Shanghai, China
01.03.TFF Pharmaceuticals, Inc. and Catalent Announce Their Collaboration Agreement Focused o..
28.02.Catalent's Dartisla ODT Peptic Ulcer Drug Available in US
15.02.CATALENT : Expands Temperature-Controlled Clinical Supply Capabilities in Shanghai, China
09.02.INSIDER SELL : Catalent
07.02.CATALENT : Recognized as a US and UK Country Certified Top Employer 2022
01.02.Health Care Stocks Back Near Even For Tuesday Trading
01.02.Health Care Stocks Losing More Ground This Afternoon
01.02.CATALENT, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
01.02.Catalent, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended Dec..
01.02.TRANSCRIPT : Catalent, Inc., Q2 2022 Earnings Call, Feb 01, 2022
01.02.Catalent, Inc. revises Earnings Guidance for the Fiscal Year 2022
01.02.CATALENT : CTLT FY22 Q2 Earnings Call Presentation
01.02.Catalent Fiscal Q2 Adjusted EPS, Revenue Rise; Full-Year 2022 Guidance Lifted -- Shares..
01.02.CATALENT : Fiscal Q2 Earnings Snapshot
01.02.CATALENT : Reports Second Quarter Fiscal 2022 Results - Form 8-K
01.02.CATALENT, INC. : Results of Operations and Financial Condition, Amendments to Articles of ..
01.02.Catalent, Inc. Reports Second Quarter Fiscal 2022 Results
01.02.Earnings Flash (CTLT) CATALENT Posts Q2 Revenue $1.22B, vs. Street Est of $1.15B
01.02.NORTH AMERICAN MORNING BRIEFING : Stocks Futures -2-
25.01.CATALENT : Completes $10 Million Expansion of High Potency Micronization Capabilities at U..
21.01.Catalent, Inc. Announces Second Quarter Fiscal Year 2022 Earnings Conference Webcast
19.01.Catalent Launches New Xpress Pharmaceutics Service to Expedite Development of Oral Drug..
18.01.CATALENT : Launches New Xpress Pharmaceutics™ Service to Expedite Development of Ora..
11.01.CATALENT : Increases Specialized Packaging Capabilities at its Philadelphia Facility to Su..
10.01.Catalent to Seek M&A
10.01.TRANSCRIPT : Catalent, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-09..
10.01.CATALENT : Investor Presentation – J.P. Morgan Healthcare Conference
05.01.AT&T, Walmart rise; PG&E, Catalent fall
05.01.Catalent Promotes COO Alessandro Maselli to Chief Executive
05.01.CATALENT : Announces Plan for Alessandro Maselli to Become New CEO Effective July 1, 2022 ..
05.01.CATALENT, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Fina..
05.01.Catalent, Inc. Announces Executive Changes
05.01.Catalent, Inc. Announces CEO Succession
05.01.Catalent Announces Plan for Alessandro Maselli to Become New CEO Effective July 1, 2022
1  2  3  4  5  6  7  8  9  10Weiter
Offizielle Publikationen
13.06.Bericht 
13.06.Bericht 
03.05.Pressemitteilung 
03.05.SEC Filing 10Q-3 
01.02.Pressemitteilung 
01.02.SEC Filing 10Q-2